To address the challenge of accurately detecting liver cell injury, we are leveraging blood biomarkers that enable sensitive detection to develop diagnostic products for the medical market. By achieving highly accurate disease severity diagnosis that was difficult with conventional methods, we are exploring commercialization aimed at realizing a society where early diagnosis and screening are commonplace.
Akiko Eguchi
Associate Professor, Mie univ.